Miller Capital Partners »

Sab Biotherapeutics shares owned by Miller Capital Partners

Quarter-by-quarter ownership of Sab Biotherapeutics (SABS) shares owned by Miller Capital Partners from 13F filings

Historical chart of Miller Capital Partners investment in Sab Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Sab Biotherapeutics held by Miller Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sab Biotherapeutics by Miller Capital Partners

Quarter filed Position value Share count Share price at filing
2026-06-30 $50k 13k 3.90

More positions owned by Miller Capital Partners

Lam Research Corp Com New (LRCX)
Asml Hldg Nv N Y Registry Shs (ASML)
Vanguard Specialized Funds Div App Etf (VIG)
Vanguard Scottsdale Fds Int-term Corp (VCIT)
Costco Wholesale Corporation (COST)
Deere & Company (DE)
Microsoft Corporation (MSFT)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Eli Lilly & Co. (LLY)
Lumen Technologies Call Call Option (Principal) (LUMN)
Ciena Corp Com New (CIEN)
Parker-Hannifin Corporation (PH)
Kla Corp Com New (KLAC)
On Semiconductor Corp Call Call Option (Principal) (ON)
Marathon Petroleum Corp (MPC)

View all positions for Miller Capital Partners

Top funds holding Sab Biotherapeutics

Vivo Capital
Caligan Partners
Perceptive Advisors
Commodore Capital
RA Capital Management
Balyasny Asset Management
Adage Capital Partners GP
Millennium Management
Woodline Partners
Vanguard Capital Management
Sessa Capital IM
Boothbay Fund Management
Ameriprise Financial
Ensign Peak Advisors
Propel Bio Management

View all funds holding Sab Biotherapeutics